Copyright
©The Author(s) 2016.
World J Hepatol. Nov 18, 2016; 8(32): 1392-1401
Published online Nov 18, 2016. doi: 10.4254/wjh.v8.i32.1392
Published online Nov 18, 2016. doi: 10.4254/wjh.v8.i32.1392
Table 6 Validation results done on the studied selected groups
| Stage of fibrosis | Predicted group membership | Total | ||
| Mild fibrosis | Moderate fibrosis | Advanced fibrosis | ||
| Count | ||||
| Mild fibrosis | 119 | 50 | 8 | 177 |
| Moderate fibrosis | 16 | 34 | 14 | 64 |
| Advanced fibrosis | 5 | 19 | 65 | 89 |
| Percent | ||||
| Mild fibrosis | 67.2 | 28.2 | 4.5 | 100.0 |
| Moderate fibrosis | 25.0 | 53.1 | 21.9 | 100.0 |
| Advanced fibrosis | 5.6 | 21.3 | 73.0 | 100.0 |
- Citation: Khattab M, Sakr MA, Fattah MA, Mousa Y, Soliman E, Breedy A, Fathi M, Gaber S, Altaweil A, Osman A, Hassouna A, Motawea I. Novel non-invasive biological predictive index for liver fibrosis in hepatitis C virus genotype 4 patients. World J Hepatol 2016; 8(32): 1392-1401
- URL: https://www.wjgnet.com/1948-5182/full/v8/i32/1392.htm
- DOI: https://dx.doi.org/10.4254/wjh.v8.i32.1392